rs120074124
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_001318088.2(SMPD1):c.-51T>C variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.0000161 in 1,614,056 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001318088.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152164Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251474Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135912
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461892Hom.: 0 Cov.: 36 AF XY: 0.0000165 AC XY: 12AN XY: 727248
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152164Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74344
ClinVar
Submissions by phenotype
Niemann-Pick disease, type A Pathogenic:5
- -
NM_000543.4(SMPD1):c.911T>C(L304P, aka L302P) is classified as pathogenic in the context of SMPD1-related Niemann-Pick disease. Sources cited for classification include the following: PMID 18815062, 21502868 and 1391960. Classification of NM_000543.4(SMPD1):c.911T>C(L304P, aka L302P) is based on the following criteria: This is a well-established pathogenic variant in the literature that has been observed more frequently in patients with clinical diagnoses than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. -
- -
Variant summary: The c.911T>C (p.Leu304Pro, alternatively known as L302P) variant in SMPD1 gene is a missense change that alters a highly conserved nucleotide. The variant, located in the MPP_ASMase domain, is predicted to be deleterious by 5/5 in silico tools. In vitro/vivo functional studies showed that this variant caused severely reduced enzymatic activity. The variant was absent from the large and broad cohorts of the ExAC project (0/121366 chromosomes). The variant was identified in several affected individuals, including multiple homozygotes, with an established diagnosis of NPD-A. Levran (1992) reported the frequency of the variant of interest in affected individuals of Ashkenazi Jewish origin with type A NPD was greater than 20% and called it the second most common disease-causing allele in AJ. Lastly, multiple reputable databases/diagnostic centers classified the variant of interest as Pathogenic. Taken together, the variant was classified as Pathogenic. -
- -
Niemann-Pick disease, type A;C0268243:Niemann-Pick disease, type B Pathogenic:2
This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 304 of the SMPD1 protein (p.Leu304Pro). This variant is present in population databases (rs120074124, gnomAD 0.04%). This missense change has been observed in individuals with Niemann-Pick type A disease (PMID: 1391960, 8401540, 10464620, 26169695). This variant is also known as p.L302P,. ClinVar contains an entry for this variant (Variation ID: 2989). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMPD1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects SMPD1 function (PMID: 1391960, 26499107). For these reasons, this variant has been classified as Pathogenic. -
- -
not provided Pathogenic:2
- -
Common pathogenic variant in Ashkenazi Jewish patients with Niemann-Pick disease, type A (PMID: 1391960); Expression studies show that L304P abolishes sphingomyelin phosphodiesterase 1 enzyme activity (PMID: 1391960); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 18815062, 8401540, 23535491, 37347058, 26320887, 36907956, 37069638, 24446175, 30788890, 26169695, 32280632, 1391960) -
Sphingomyelin/cholesterol lipidosis Pathogenic:1Other:1
1 of 3 common variants that accounts for more than 90% of pathogenic variants in persons of Ashkenazi Jewish ancestry with Niemann-Pick disease type-A -
The p.Leu304Pro variant in SMPD1 (also known as p.Leu302Pro due to a difference in cDNA numbering) has been reported in at least 5 individuals with Niemann-Pick disease (PMID: 8401540, 1391960, 18815062) and has been identified in 0.040% (4/10080) of Ashkenazi Jewish chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs120074124). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (VariationID: 2989) as Pathogenic by Counsyl, Integrated Genetics, EGL Genetic Diagnostics, OMIM, and GeneReviews. In vitro functional studies provide some evidence that the p.Leu304Pro variant may impact protein function (PMID: 1391960, 18815062). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The presence of this variant in at least 1 affected homozygote and in combination with a reported pathogenic variant in an individual with Niemann-Pick disease increases the likelihood that the p.Leu304Pro variant is pathogenic (VariaitionID: 2990; PMID: 8401540, 1391960, 18815062). The p.Leu304Pro variant is located in a region of SMPD1 that is essential to protein folding and stability, suggesting that this variant is in functional domain and supports pathogenicity (PMID: 27725636, 30788890). The phenotype of an individual homozygous for this variant is highly specific for Niemann-Pick disease based on acid sphingomyelinase activity being <10% of normal, consistent with disease. In summary, this variant meets criteria to be classified as pathogenic for Niemann-Pick disease in an autosomal recessive manner based on the in vitro functional studies, its importance in maintaining structure, and its presence in affected homozygous and compound heterozygous individuals. ACMG/AMP Criteria applied: PS3, PM3, PM1, PM2_supporting, PP3, PP4 (Richards 2015). -
Niemann-Pick disease, type B Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at